Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67

1.

Clinical impacts of inflammatory markers and clinical factors in patients with relapsed or refractory diffuse large B-cell lymphoma.

Kim DY, Song MK, Chung JS, Shin HJ, Yang DH, Lim SN, Oh SY.

Blood Res. 2019 Dec;54(4):244-252. doi: 10.5045/br.2019.54.4.244. Epub 2019 Dec 20.

2.

Resistance Mechanisms to CAR T-Cell Therapy and Overcoming Strategy in B-Cell Hematologic Malignancies.

Song MK, Park BB, Uhm JE.

Int J Mol Sci. 2019 Oct 10;20(20). pii: E5010. doi: 10.3390/ijms20205010. Review.

3.

Understanding Immune Evasion and Therapeutic Targeting Associated with PD-1/PD-L1 Pathway in Diffuse Large B-cell Lymphoma.

Song MK, Park BB, Uhm J.

Int J Mol Sci. 2019 Mar 15;20(6). pii: E1326. doi: 10.3390/ijms20061326. Review.

4.

The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma.

Lee GW, Park SW, Go SI, Kim HG, Kim MK, Min CK, Kwak JY, Bae SB, Yoon SS, Lee JJ, Kim KH, Nam SH, Mun YC, Kim HJ, Bae SH, Shin HJ, Lee JH, Park JS, Jeong SH, Lee MH, Lee HS, Park KW, Lee WS, Lee SM, Lee JO, Hyun MS, Jo DY, Lim SN, Lee JH, Kim H, Cho DY, Do YR, Kim JA, Park SK, Kim JS, Kim SJ, Yi HG, Moon JH, Choi CW, Kim SH, Kim BS, Park MR, Shim H, Song MK, Kim Y, Kim K.

Acta Haematol. 2018;140(3):146-156. doi: 10.1159/000490488. Epub 2018 Sep 25.

PMID:
30253397
5.

Understanding Splenomegaly in Myelofibrosis: Association with Molecular Pathogenesis.

Song MK, Park BB, Uhm JE.

Int J Mol Sci. 2018 Mar 18;19(3). pii: E898. doi: 10.3390/ijms19030898. Review.

6.

Tumor necrosis and complete resection has significant impacts on survival in patients with limited-stage upper aerodigestive tract NK/T cell lymphoma.

Song MK, Chung JS, Yhim HY, Lim SN, Kim SJ, Han YH, Shim HK, Jung SH, Lee JJ, Yang DH.

Oncotarget. 2017 May 23;8(45):79337-79346. doi: 10.18632/oncotarget.18107. eCollection 2017 Oct 3.

7.

Would Lipophilic Statin Therapy as a Prognostic Factor Improve Survival in Patients With Uterine Cervical Cancer?

Song MK, Shin BS, Ha CS, Park WY.

Int J Gynecol Cancer. 2017 Sep;27(7):1431-1437. doi: 10.1097/IGC.0000000000001046.

PMID:
28644162
8.

A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma.

Kim MK, Kim K, Min CK, Kwak JY, Bae SB, Yoon SS, Lee JJ, Kim KH, Nam SH, Mun YC, Kim HJ, Bae SH, Shin HJ, Lee JH, Park JS, Jeong SH, Lee MH, Kim YS, Lee HS, Park KW, Lee WS, Lee SM, Lee JO, Hyun MS, Jo DY, Lim SN, Lee JH, Cho DY, Do YR, Kim JA, Park SK, Kim JS, Kim SJ, Kim H, Yi HG, Moon JH, Choi CW, Kim SH, Joo YD, Kim HG, Kim BS, Park MR, Song MK, Kim SY.

Oncotarget. 2017 Jun 6;8(23):37605-37618. doi: 10.18632/oncotarget.16790.

9.

Evaluation of prognostic factors in patients with relapsed AML: Clonal evolution versus residual disease.

Kim H, Seol YM, Song MK, Choi YJ, Shin HJ, Park SH, Lee EY, Chung JS.

Blood Res. 2016 Sep;51(3):175-180. Epub 2016 Sep 23.

10.

Tumor necrosis could reflect advanced disease status in patients with diffuse large B cell lymphoma treated with R-CHOP therapy.

Song MK, Chung JS, Shin DY, Lim SN, Lee GW, Choi JC, Park WY, Oh SY.

Ann Hematol. 2017 Jan;96(1):17-23. doi: 10.1007/s00277-016-2822-8. Epub 2016 Sep 28.

PMID:
27677489
11.

Clinical impact of induction treatment modalities and optimal timing of radiotherapy for the treatment of limited-stage NK/T cell lymphoma.

Moon JH, Lee BH, Kim JA, Lee YJ, Chae YS, Yhim HY, Kwak JY, Do YR, Park Y, Song MK, Shin HJ, Kim T, Lee JJ, Yang DH.

Leuk Res. 2016 Oct;49:80-7. doi: 10.1016/j.leukres.2016.08.015. Epub 2016 Aug 31.

PMID:
27608179
12.

Usefulness of spleen volume measured by computed tomography for predicting clinical outcome in primary myelofibrosis.

Song MK, Chung JS, Lim SN, Lee GW, Lee SM, Lee NK, Choi JC, Oh SY.

Int J Hematol. 2016 Oct;104(4):476-84. doi: 10.1007/s12185-016-2050-y. Epub 2016 Jun 27.

PMID:
27349913
13.

High total metabolic tumor volume in PET/CT predicts worse prognosis in diffuse large B cell lymphoma patients with bone marrow involvement in rituximab era.

Song MK, Yang DH, Lee GW, Lim SN, Shin S, Pak KJ, Kwon SY, Shim HK, Choi BH, Kim IS, Shin DH, Kim SG, Oh SY.

Leuk Res. 2016 Mar;42:1-6. doi: 10.1016/j.leukres.2016.01.010. Epub 2016 Jan 24.

PMID:
26851438
14.

Mutational analysis of SH2B3 in Korean patients with BCR-ABL1 negative myeloproliferative neoplasm.

Kim N, Kim IS, Chang CL, Lee EY, Kim HH, Song MK, Shin HJ, Chung JS.

Ann Lab Med. 2016 Jan;36(1):67-9. doi: 10.3343/alm.2016.36.1.67. No abstract available.

15.

A case of simultaneous presentation of symptomatic PCM and MDS unrelated to prior chemotherapy.

Kim H, Park SH, Lee EY, Song MK.

Blood Res. 2015 Sep;50(3):179-81. doi: 10.5045/br.2015.50.3.179. Epub 2015 Sep 22. No abstract available.

16.

Is there role of additional chemotherapy after definitive local treatment for stage I/II marginal zone lymphoma?: Consortium for Improving Survival of Lymphoma (CISL) study.

Koh MS, Kim WS, Kim SJ, Oh SY, Yoon DH, Lee SI, Hong J, Song MK, Shin HJ, Kwon JH, Kim HJ, Do YR, Suh C, Kim HJ.

Int J Hematol. 2015 Oct;102(4):420-5. doi: 10.1007/s12185-015-1845-6. Epub 2015 Jul 26.

PMID:
26210384
17.

Maximum standardized uptake value on positron emission tomography/computed tomography predicts clinical outcome in patients with relapsed or refractory diffuse large B-cell lymphoma.

Jang HR, Song MK, Chung JS, Yang DH, Lee JO, Hong J, Cho SH, Kim SJ, Shin DH, Park YJ, Kang JS, Lee JE, Lee MW, Shin HJ.

Blood Res. 2015 Jun;50(2):97-102. doi: 10.5045/br.2015.50.2.97. Epub 2015 Jun 25.

18.

Incidences and Prognostic Impact of c-KIT, WT1, CEBPA, and CBL Mutations, and Mutations Associated With Epigenetic Modification in Core Binding Factor Acute Myeloid Leukemia: A Multicenter Study in a Korean Population.

Park SH, Lee HJ, Kim IS, Kang JE, Lee EY, Kim HJ, Kim YK, Won JH, Bang SM, Kim H, Song MK, Chung JS, Shin HJ.

Ann Lab Med. 2015 May;35(3):288-97. doi: 10.3343/alm.2015.35.3.288. Epub 2015 Apr 1.

19.

Risk stratification model in elderly patients with multiple myeloma: clinical role of magnetic resonance imaging combined with international staging system and cytogenetic abnormalities.

Song MK, Chung JS, Lee JJ, Lee JH, Song IC, Lee SM, Shin DY, Lee GW, Lee IS.

Acta Haematol. 2015;134(1):7-16. doi: 10.1159/000370235. Epub 2015 Mar 28.

PMID:
25832367
20.

The t(11;14)(q13;q32) translocation as a poor prognostic parameter for autologous stem cell transplantation in myeloma patients with extramedullary plasmacytoma.

Shin HJ, Kim K, Lee JJ, Song MK, Lee EY, Park SH, Kim SH, Jang MA, Kim SJ, Chung JS.

Clin Lymphoma Myeloma Leuk. 2015 Apr;15(4):227-35. doi: 10.1016/j.clml.2014.12.007. Epub 2014 Dec 12.

PMID:
25812994

Supplemental Content

Loading ...
Support Center